About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Current Search
Report Type
Organization
Disposition
Year
Month
Found 487 record(s)
Req # A-2024-000091
Adverse Drug Reaction (ADR) for AVOBENZONE. Report number: 001060287. ADR for . Report number: 001060638. ADRs for HYDROCORTISONE. Report numbers: 001061825, 001063444. ADR for LISTERINE. Report number: 001068710. ADRs for FAMOTIDINE. Report numbers…Organization: Health Canada
May 2024
Req # A-2024-000092
Adverse Drug Reaction (ADR). Report number: 001074892.Organization: Health Canada
May 2024
Req # A-2024-000110
Adverse Drug Reaction (ADR). Report number: 001075789.Organization: Health Canada
May 2024
Req # A-2024-000112
Adverse Drug Reaction (ADR) for Privigen. Report number: 001052985.Organization: Health Canada
May 2024
Req # A-2024-000121
Adverse Drug Reaction (ADR) for Privigen. Report number: E2B_001066628.Organization: Health Canada
May 2024
Req # A-2024-000156
Adverse Drug Reaction (ADR) for Venofer. Report number: 001078256.Organization: Health Canada
May 2024
Req # A-2024-000167
Adverse Drug Reaction (ADR) for Technetium (Tc 99m). Report number: 001075778.Organization: Health Canada
May 2024
Req # A-2022-00011
Obtain a complete copy of each of these briefing notes: Briefing Note: CEO Quarterly Meeting with the Alberta Energy Regulator – 26 January 2023 (Ref. # 1447170) Briefing Note: CEO Monthly Meeting with Trans Mountain Corporation – 25 January 2023 (…Organization: Canada Energy Regulator
May 2023
Req # A-2023-00001
Requesting the number of Professional Engineers and Geoscientists on the CER staff (or on contract) within the last ten years registered in the Provinces of British Columbia and or Alberta, as members and/or permit-to-practice holders. List to…Organization: Canada Energy Regulator
May 2023
Req # A-2015-000351
Application submissions and summary for new drug deferiprone licencing. Common Drug Review minutes kept of review process, Canadian Agency fo Drugs and Technologies in Health's (CADTH) interim and final report. Records from January 1, 2012 to…Organization: Health Canada
May 2023